Reviewer3 vs q.e.d Science: Two AI Review Tools, Different Approaches

In our pre-submission review work, these two products usually show up for different reasons. We see Reviewer3 chosen by labs that want a fast, repeatable screen before internal circulation. We see q.e.d Science chosen when the manuscript argument itself feels shaky and co-authors are debating whether the claims really follow from the evidence.

Our review of the current public materials points to a real product-shape difference, not just different marketing. Reviewer3 emphasizes named review checks, explicit pricing, and a security page that says its SOC 2 Type II coverage comes from its infrastructure providers rather than its own audit. q.e.d emphasizes core claims, originality framing, a bioRxiv pilot, and a security page that says research inputs are not used for training and cites its own SOC 2 Type II audit. That matters if your lab has strict unpublished-data rules.

Speed. "A full panel back in minutes" vs typically about 30 minutes for q.e.d. If you need feedback in the next few minutes, Reviewer3 is faster.

Named checks. Separate checks for submission screening, references, fatal flaws, claims, and code replication give structured feedback, ordered by severity in one report.

Integrity checking. Reviewer3's Submission Screening flags leftover AI prompts, and its Reference Check flags hallucinated and retracted references. Broader integrity checks are listed on the Teams plan.

Code replication. Reviewer3 runs the paper's code and compares the output with what the paper reports, which q.e.d does not advertise.

Core-claim analysis. This is q.e.d's distinctive feature. It breaks the paper into its core claims, surfaces the gaps in evidence and reasoning, and suggests tailored fixes. Few tools put argument structure this close to the center of the review.

Originality ranking. q.e.d separates your novel contributions from existing knowledge and ranks them against studies in your field. This is useful for calibrating novelty claims, which is one of the most common sources of reviewer pushback.

Academic credibility. q.e.d says it was "built by scientists, for scientists" and shows testimonials from researchers at institutions including Harvard, Yale, UC Berkeley, and Oxford. bioRxiv chose it for its first pilot with an AI review tool.

Lower barrier to entry. Free for researchers who sign up with an institutional email. Reviewer3 has no free tier.

Both Reviewer3 and q.e.d are AI-only tools. Neither advertises the full set below:

• Literature-completeness checks. Reviewer3's Reference Check flags hallucinated, retracted, irrelevant, and self-cited references; q.e.d does not advertise a citation check. Neither says it checks whether you are missing a competing paper from 3 months ago.

• Vision-based figure analysis. Neither advertises figure, table, or supplementary-panel analysis, such as whether Figure 3B is missing error bars or your microscopy images lack scale bars.

• Quantitative journal-fit scoring. Neither advertises journal-fit scoring, a calibrated desk-reject risk score, or ranked alternatives.

• Human expert review. Neither tool puts a named scientist on your paper. Manusights does not either: it is AI-only, so when field judgment from a person matters most, a senior colleague in your subfield is still the read to get.

These are the failure modes that actually cause most rejections at selective journals - and neither tool is built around them.

manuscript readiness check provides what both Reviewer3 and q.e.d lack:

For maximum coverage:

1. Manuscript readiness check (about two to three minutes, $0) - get your readiness score and desk-reject risk
2. q.e.d - stress-test the claim logic and identify inferential gaps
3. Reviewer3 - fast triage on methodology and reproducibility
4. manuscript readiness check - verify citations, analyze figures, score journal fit
5. Fix everything flagged by all three tools
6. If the submission is career-critical, step up to the $99 Submission-Ready Dossier, which adds a mock review from four reviewer viewpoints, the objections those reviewers are likely to raise, and a target-journal plan with backup venues

This uses each tool for its strongest job: q.e.d for logic, Reviewer3 for methodology, Manusights for citations/figures/journal-fit and the final submission decision.

Use Reviewer3 for fast first-pass screening when you need structured feedback on methodology, references, and reproducibility in minutes.

Use q.e.d Science when the paper's biggest risk is logical structure, claims that don't follow from evidence, or evidence that doesn't connect to the right claims.

Use manuscript readiness check when you need citation verification, figure analysis, or journal-specific scoring, the gaps that cause actual desk rejections at selective journals. Start with the free scan, then decide whether the $39 Full Review or the $99 Dossier fits your situation.